ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PGEN vs MBX // RSI-14 & 200D SMA MOMENTUM

Precigen Inc. (NASDAQ) VS. MBX Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: PGEN 1 — MBX 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: MBX
rsi-technicals
32.6
rsi-technicals
49.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGEN VS. MBX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PGEN MBX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -26.40% -8.60 MBX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.78% -3.12% -0.66 MBX /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 146.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 PGEN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 32.6 49.9 -17.30 MBX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.84B $2.62B -$779.6M MBX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PGEN REV MBX REV PGEN GROSS % MBX GROSS % PGEN FCF MBX FCF
FY 2025 $9.7M $274.6M — — -$89.8M -$81.9M
FY 2024 $3.9M $190.9M — — -$76.8M -$55.6M
FY 2023 $6.2M $98.9M — — -$66.9M -$32.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGEN // BETA —
MBX // BETA —